세계의 임상화학 시장 보고서(2025년)
Clinical Chemistry Global Market Report 2025
상품코드 : 1821543
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

임상화학 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 8.0%로 218억 8,000만 달러로 성장합니다. 예측 기간의 성장은 정밀의료에 대한 수요 증가, 바이오마커 탐색에 대한 수요 증가, 개인 맞춤형 헬스케어에 대한 수요 증가, 신종 감염병, 원격의료 및 원격 모니터링에 기인하는 것으로 분석됩니다. 예측 기간의 주요 동향으로는 고급 분석 기술, AI와 머신러닝의 통합, 기술 혁신, 실험실 자동화, 최첨단 솔루션 등이 있습니다.

향후 5년간 8.0%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 스위스나 한국에서 개발된 고처리량 화학 분석기 및 시약 검사 키트의 가격을 급등시키고, 검사 결과 지연 및 병원 검사실 운영 비용 상승을 초래하여 미국의 검사실 의료에 지장을 초래할 수 있습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

만성질환의 유병률 증가가 예상되며, 임상화학 시장의 성장을 촉진할 것으로 예측됩니다. 만성질환은 유병기간이 길고 지속적인 치료가 필요한 것이 특징이며, 당뇨병, 암, 심장병 등의 질환이 사망과 신체장애의 주요 원인이 되어 전 세계 건강에 큰 영향을 미치고 있습니다. 임상화학은 심혈관 질환, 당뇨병, 호르몬 장애 등 다양한 만성질환의 상태와 위험을 평가하는 기술의 개발 및 개선에 중요한 역할을 하고 있습니다. 또한 감염성 질환 및 독감 관련 검사실 대응도 지원하고 있습니다. 세계보건기구(WHO)의 2023년 9월 보고서에 따르면 만성질환은 전 세계 사망원인의 74%를 차지하며 매년 4,100만 명이 사망하고 있습니다. 따라서 만성질환의 유병률 증가는 임상화학 시장의 성장에 중요한 촉진요인입니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Clinical chemistry is a field within medical laboratory sciences that emphasizes the qualitative and quantitative analysis of bodily fluids, primarily blood and urine, for diagnosing and monitoring diseases. This discipline involves measuring various biochemical markers or analytes using advanced analytical techniques, delivering essential information that assists healthcare professionals in making informed clinical decisions.

The primary product categories in clinical chemistry comprise analyzers, reagents, and consumables. The term 'analyzer' refers to a laboratory device used to determine the concentration of specific compounds in samples of serum, plasma, urine, and other bodily fluids. These analyzers initiate reactions using reagents, typically applied to the pale-yellow supernatant part (serum) obtained from centrifuged blood or urine samples. Various applications of clinical chemistry include general chemistry tests, liver function tests, kidney function tests, urinalysis, electrolyte panels, lipid profiles, specialty chemical tests, and others. These products find application in hospitals, diagnostic and pathology centers, ambulatory surgery centers, and various other end-user settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical chemistry market research report is one of a series of new reports from The Business Research Company that provides clinical chemistry market statistics, including clinical chemistry industry global market size, regional shares, competitors with clinical chemistry market share, detailed clinical chemistry market segments, market trends and opportunities, and any further data you may need to thrive in the clinical chemistry industry. This anomaly detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The clinical chemistry market size has grown strongly in recent years. It will grow from $15.11 billion in 2024 to $16.06 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased diagnostic testing demand, healthcare industry growth, aging population, increased disease diagnosis and management, and research and development.

The clinical chemistry market size is expected to see strong growth in the next few years. It will grow to $21.88 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing demand for precision medicine, growing need for biomarker discovery, increasing demand for personalized healthcare, emerging infectious diseases, and telemedicine and remote monitoring. Major trends in the forecast period include advanced analytical techniques, ai and machine learning integration, technological innovations, laboratory automation, and cutting-edge solutions.

The forecast of 8.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. laboratory medicine by inflating prices of high-throughput chemistry analyzers and reagent test kits developed in Switzerland and South Korea, resulting in delayed test results and higher hospital lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The anticipated increase in the prevalence of chronic diseases is expected to drive the growth of the clinical chemistry market. Chronic diseases, characterized by prolonged duration and the need for continuous medical care, significantly impact global health, with conditions such as diabetes, cancer, and heart disease being leading causes of death and disability. Clinical chemistry plays a vital role in developing and improving techniques for assessing the status and risk of various chronic diseases, including cardiovascular disease, diabetes, and hormone disorders. Additionally, it supports laboratory initiatives related to infectious diseases and flu. According to a September 2023 report from the World Health Organization (WHO), chronic diseases account for 74% of global deaths, totaling 41 million people annually. Hence, the increasing prevalence of chronic diseases is a key driver for the growth of the clinical chemistry market.

The growth of the clinical chemistry market is further fueled by the rising geriatric population. This demographic, consisting of individuals aged 65 or older, plays a crucial role in the demand for clinical chemistry, as it is instrumental in managing age-related diseases such as diabetes, cardiovascular issues, and osteoporosis. According to an October 2022 report from the World Health Organization, the global elderly population is projected to reach 2.1 billion by 2050, with 1 in 6 individuals expected to be 60 or older by 2030. The increasing geriatric population is thus a significant factor contributing to the growth of the clinical chemistry market.

Technological advancements are a significant trend gaining traction in the clinical chemistry market. Leading companies in the clinical chemistry sector are concentrating on integrating new technological solutions to enhance their market position. For example, in May 2022, Mindray, a China-based medical device manufacturer, introduced the BS-600M, a robust clinical chemistry analyzer designed for medium-volume laboratories. This analyzer enhances productivity and reliability in test processing and includes on-board hemolysis for whole blood samples used in HbA1c tests, thus eliminating the need for manual pretreatment. This innovation boosts testing efficiency while minimizing biohazard risks and reducing human errors.

Major companies operating in the clinical chemistry market are intensifying their focus on introducing advanced diagnostic systems, such as the Atellica CI Analyzer, to gain a competitive edge in the market. The Atellica CI Analyzer is a compact testing system developed by Siemens Healthineers, a Germany-based healthcare company. Launched in July 2023, this analyzer is designed to address challenges faced by laboratories in delivering high-quality diagnostics and improving community health. Equipped with features like microvolume technology, an IMT sensor, and independent integration, the Atellica CI Analyzer maximizes test yield, ensures quality results, and maintains high throughput. Offering a comprehensive range of over 200 assays across 20 disease states, it aids in standardizing results and streamlining workflows for entire lab networks.

In May 2024, Bruker, a US-based company that specializes in the design, manufacture, and sale of scientific instruments as well as analytical and diagnostic solutions, acquired ELITechGroup for $954.6 million. This acquisition is intended to strengthen Bruker's position in the molecular diagnostics market, particularly in the infectious disease diagnostics sector. By integrating ELITech's extensive portfolio of molecular diagnostic systems and assays, Bruker seeks to expand its capabilities in infectious disease testing, including viral testing, which is essential for contemporary healthcare requirements. ELITechGroup, based in Italy, develops, manufactures, and markets a wide range of diagnostic products and solutions, encompassing instruments, reagents, and software.

Major companies operating in the clinical chemistry market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Laboratory Corporation, Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A.

North America was the largest region in the chemical chemistry market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical chemistry market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the clinical chemistry market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The clinical chemistry market includes revenues earned by assays and analyzers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Chemistry Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical chemistry market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for clinical chemistry ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical chemistry market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Clinical Chemistry Market Characteristics

3. Clinical Chemistry Market Trends And Strategies

4. Clinical Chemistry Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Clinical Chemistry Growth Analysis And Strategic Analysis Framework

6. Clinical Chemistry Market Segmentation

7. Clinical Chemistry Market Regional And Country Analysis

8. Asia-Pacific Clinical Chemistry Market

9. China Clinical Chemistry Market

10. India Clinical Chemistry Market

11. Japan Clinical Chemistry Market

12. Australia Clinical Chemistry Market

13. Indonesia Clinical Chemistry Market

14. South Korea Clinical Chemistry Market

15. Western Europe Clinical Chemistry Market

16. UK Clinical Chemistry Market

17. Germany Clinical Chemistry Market

18. France Clinical Chemistry Market

19. Italy Clinical Chemistry Market

20. Spain Clinical Chemistry Market

21. Eastern Europe Clinical Chemistry Market

22. Russia Clinical Chemistry Market

23. North America Clinical Chemistry Market

24. USA Clinical Chemistry Market

25. Canada Clinical Chemistry Market

26. South America Clinical Chemistry Market

27. Brazil Clinical Chemistry Market

28. Middle East Clinical Chemistry Market

29. Africa Clinical Chemistry Market

30. Clinical Chemistry Market Competitive Landscape And Company Profiles

31. Clinical Chemistry Market Other Major And Innovative Companies

32. Global Clinical Chemistry Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Chemistry Market

34. Recent Developments In The Clinical Chemistry Market

35. Clinical Chemistry Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기